Shield Therapeutics Share Discussion Threads

[qipincha] 28/9/2023 21:54

you can watch the meeting this afternoon, here is the link
hxxps://presentations.investormeetcompany.com/investor-meet-company/SHIELD-THERAPEUTICS-PLC-Interim-results-ffedfc28f57bb9e9512c1942?bmid=540e3c395fc7

[reviewwworld] 28/9/2023 21:37

They are so obvious with hindsight. Sadly they got me on a few occasions.

[reviewwworld] 28/9/2023 21:12

Complete BS Patt. You're one of the worst on here. You were pushing buys at 60p+ and all the way down. There ain't a chance in hell any of those were real or that your average is 9p. As another member outed you, you're a certified fraud/crook and the sooner you disappear the better

[jimbren] 28/9/2023 21:10

Small beer vs US story, I know, but why did European royalties drop nearly 50% 6m/6m from $1.014m to $0.592m while sales rose 19%?
Royalties are paid late? But a drop in 1H22's $0.752m as well?
What is the deal with Norgine?
At least Norgine are hiring quite a few more UK sales reps.

[tripletop1] 28/9/2023 20:41

Useful summary of today's developments:

[skcots48] 28/9/2023 19:55

Fair enough

[tripletop1] 28/9/2023 19:51

32m traded, I'm sure they all weren't sells else we'd be sitting at New all time lows.. the big players will be hoovering up a lot of stock from the "peeved had enough of this BS" PI's

Hopefully hold the 7's and build from there..

Slow and steady I imagine

More pressure than ever for them to keep getting those Rx writers on board, coupled with the new focus of increasing the average selling price.

[purchaseatthetop] 28/9/2023 18:24

My average is 9.1p so I am in the red now. They did not say they needed more money amaretto but it was clear that even though the forecast was going cash positive Q4 24 that did not mean they could go down to fumes. The covenants prevent that. The key to be is prescription numbers.

[cordwainer] 28/9/2023 18:19

Unusually steep loan covenants. Genuine risk of further placings despite prospect of continued strong revenue growth.

[bolitix] 28/9/2023 17:40

Incidentally I have voted against every proposal put forward since this CEO took over and think we all should to get him out. He rabbited on for ages with material we already know or don't value. We need someone who can get that cash-burn down and understands shareholders

[bolitix] 28/9/2023 17:36

The CEO is still a Donkey. They should have released the REX and SWK emails after the Conference today and explained something was coming. I asked them to drop the REX agenda as there has to be an alternative to further share dilution to raise £5m. The Share reacted and now no value in taking that forward regardless. I think all they were trying to do is offload shares they did not sell at 6p last time. If they waited with those 2 emails the share price would be over 20p on those 3Q numbers. They always said they would be cash positive YE24-just how they get there and the cash-burn lacked transparency.

[eeza] 28/9/2023 17:34

"I doubt the sub 8p shares will be around for long."

Yes, the same was said at the 6.0p placing. How did that pan out?

[cyberbub] 28/9/2023 17:22

Is anyone clear on what participation Viatris have made in the fundraising today? There is a 50-50 JV in effect, so have Viatris also committed $20M (of course they will have the cash) to bolster their half of the sales and marketing effort?

[best1467] 28/9/2023 17:22

Well they did not read out any of the 20 or so questions I read through all related to the equity raise and debt.
These meetings as far as PI getting questions answered are pointless

[devonlad] 28/9/2023 17:22

I didn't see it like that Jimbren but hey ho, we all interpret things differently. I thought the solution to getting the prescription value up a lot higher was pretty neat. Half the issue is that this is a UK company working in the USA healthcare system and we don't necessarily understand how it works.

[parob] 28/9/2023 17:17

I doubt the sub 8p shares will be around for long. Quite a few have thrown the towel in today causing the dip under placing price, but it will be temporary imo.

[jimbren] 28/9/2023 17:17

But economics of Viatris tie up not so great, and maybe bettter if we do the bulk of the sales.

[jimbren] 28/9/2023 17:16

We watch the data each week on sales, Shield vs Viatris. Lack of effusive praise of Viatris is possibly telling.

[cyberbub] 28/9/2023 17:05

Skots I don't think that's as important a question as some others, to be fair. Anyone who thinks 8p is good value has been given an opportunity by Mr Market to buy cheaper - the company don't directly control Mr Market.

[skcots48] 28/9/2023 16:55

Question for them: how are you supporting retail investors if you offer is above the share price & a 0.5% commission is charged?And how will this potential shortfall of 1.4m you have planned be filled?

[devonlad] 28/9/2023 16:52

Quite interesting how they are going to tweak their model to improve the sale value. Quite simple and easy to implement.